Ting v Chief Executive, Queensland Health

Link copied
Case Copied 53 min read

QUEENSLAND CIVIL AND
ADMINISTRATIVE TRIBUNAL


CITATION:

Ting v Chief Executive, Queensland Health [2020] QCAT 265

PARTIES: DR JOHN YUK CHING TING

(applicant)

v

CHIEF EXECUTIVE, QUEENSLAND HEALTH

(respondent)

APPLICATION NO/S:

GAR084-19

MATTER TYPE:

General administrative review matters

DELIVERED ON:

28 July 2020

HEARING DATE:

8 – 9 October 2019

HEARD AT:

Brisbane

DECISION OF:

Allen QC DCJ, Deputy President

ORDERS:

The decision of the respondent is confirmed.

CATCHWORDS:

PROFESSIONS AND TRADES – HEALTH CARE PROFESSIONALS – MEDICAL PRACTITIONERS – LICENCES AND REGISTRATION – where the applicant medical practitioner has applied for a review of the decision of the respondent pursuant to section 24 of the Health (Drugs and Poisons) Regulation 1996 to cancel the endorsements of the applicant in relation to Schedule 8 controlled drugs and Schedule 4 restricted drugs of dependency.

Criminal Law (Rehabilitation of Offenders) Act 1986 (Qld), s 9

Health Act 1937 (Qld), s 5
Health (Drugs and Poisons) Regulation 1996 (Qld), s 15, s 21, s 23, s 24, s 25A, s 33, s 58, s 78, s 81, s 120, s 122, s 161, s 213
Queensland Civil and Administrative Tribunal Act 2009 (Qld), s 19, s 20

APPEARANCES & REPRESENTATION:

Applicant:

The applicant appeared on his own behalf

Respondent:

S Munasinghe instructed by Crown Law

REASONS FOR DECISION

Introduction

[1]On 8 February 2019, Dr Susan Ballantyne, a delegate of the Chief Executive, Queensland Health (“the respondent”) decided, pursuant to section 24 of the Health (Drugs and Poisons) Regulation 1996 (“the Regulation”), to cancel the endorsements of Dr John Yuk Ching Ting (“the applicant”) under section 58 of the Regulation in relation to Schedule 8 controlled drugs and under section 161 of the Regulation in relation to Schedule 4 restricted drugs of dependency.  The applicant has applied for a review of the decision of the respondent.[1] 

[1]

[2]At all material times the applicant was registered under the Health Practitioner Regulation National Law (Queensland) to practise in the medical profession and thus[2], prior to the decision under review, held endorsements[3] under section 58 of the Regulation with respect to controlled drugs[4] and pursuant to section 161 of the Regulation with respect to restricted drugs.[5] The effect of the decision of the respondent was to cancel the applicant’s endorsement under section 58 of the Regulation in relation to Schedule 8 controlled drugs entirely and the applicant’s endorsement under section 161 of the Regulation in relation to Schedule 4 restricted drugs in part. The decision cancelled the endorsement of the applicant under section 161 of the Regulation in relation to Schedule 4 restricted drugs of dependency.[6] The applicant has retained his endorsement under section 161 of the Regulation in relation to Schedule 4 restricted drugs which are not restricted drugs of dependency.

[2]See section 36 and definitions of “medical practitioner” and “doctor” in Schedule 1 of the Acts Interpretation Act 1954 and sections 14(1) and 17 of the Statutory Instruments Act 1992.

[3]See definitions of “endorsement” and “authority” in appendix 9 of the Regulation.

[4]See definition…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Ting v Chief Executive, Queensland Health and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2020] QCAT 265
Decision Date

CaseChat Overview and Summary

The matter before the court was an application by Dr. Ting for a review of the decision of the respondent, the Chief Executive of Queensland Health, to cancel the endorsements of Dr. Ting's registration as a medical practitioner in relation to Schedule 8 controlled drugs and Schedule 4 restricted drugs of dependency. Dr. Ting challenged the decision on the grounds that it was unreasonable and not supported by the evidence.

The primary legal issue before the court was whether the decision to cancel the endorsements was lawful and reasonable. The court considered whether the respondent had a proper basis for the decision and whether the decision was supported by relevant evidence and was not irrational or unjust. The court also examined whether the respondent had acted in accordance with the statutory provisions and whether the decision was proportionate to the alleged misconduct.

In reviewing the decision, the court found that the respondent had a legitimate basis for the cancellation of the endorsements. The respondent had concluded that Dr. Ting's conduct posed a significant risk to public health and safety, particularly given his history of prescribing controlled drugs and the associated risks of dependency and diversion. The court held that the decision was supported by substantial evidence, including expert medical evidence and the findings of a previous disciplinary inquiry. The court further determined that the decision was not irrational or unjust and was proportionate to the seriousness of the misconduct. Consequently, the court confirmed the decision of the respondent to cancel the endorsements.

No additional orders were made by the court beyond confirming the decision of the respondent to cancel the endorsements of Dr. Ting's registration in relation to Schedule 8 controlled drugs and Schedule 4 restricted drugs of dependency.

Orders

Orders of the court

The decision of the respondent is confirmed.

Background

Background to the litigation

Full text does not contain this section.

Evidence

Evidence Before The Court

Full text does not contain this section.

Decision

Reasons for decision

Full text does not contain this section.

Ratio Decidendi

Legal Principle Established

Full text does not contain this section.